Amerise Biosciences Limited Share Price

Stocks

AMARDEE6

INE673C01020

Investment Holding Companies

Market Closed - Bombay S.E. Other stock markets 11:01:00 15/07/2026 BST			5-day change	1st Jan Change
0.9500 ^INR	+3.26%		+18.75%	+55.74%

05-05	Amerise Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
02-02	Amerise Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI

Valuation: Amerise Biosciences Limited

Market Cap	38.98M 406K 355K 328K 303K 570K 581K 3.91M 1.53M 19.09M 1.52M 1.49M 65.72M	P/E 2024	-29.8x	P/E 2025	1,056x
Enterprise Value	38.76M 404K 353K 326K 301K 567K 577K 3.89M 1.53M 18.98M 1.52M 1.48M 65.35M	EV / Sales 2024	121x	EV / Sales 2025	31.9x
Free-Float	69.34%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Chart: Amerise Biosciences Limited

Dynamic Chart

Latest news : Amerise Biosciences Limited

05-05	Amerise Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
02-02	Amerise Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
02-02	Amerise Biosciences appoints Albert Hines as CFO	RE
02-02	Amerise Biosciences Limited Announces Chief Financial Officer Changes, Effective February 2, 2026	CI
02-02	Amerise Biosciences Limited Announces Board Changes, Effective February 2, 2026	CI
11-05	Amerise Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
24/09/25	Amerise Biosciences Limited Appoints Kelash Bunkar as Independent Director, Effective 23 September 2025	CI
24/07/25	Amerise Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
19/05/25	Amerise Biosciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025	CI
03/02/25	Amerise Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
03/02/25	Amerise Biosciences Limited Announces Resignation of Niraj Vaghela as Independent Director	CI
27/01/25	Swagtam Trading & Services Limited announced that it expects to receive INR 61.904375 million in funding from Jalees Commercial Limited, Shree Ganesh Bio-Tech Limited, Amerise Biosciences Limited, Saianand Commercial Limited and other investors	CI
22/10/24	Amerise Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI

More news

Quotes and Performance

1 day	+3.26%
1 week	+18.75%
Current month	+15.85%
1 month	+43.94%
3 months	+35.71%
6 months	+46.15%
Current year	+55.74%

More quotes

Course Extremes

1 week	0.8	0.95
1 month	0.66	0.95
Current year	0.5	0.95
1 year	0.5	0.95
3 years	0.5	1.45
5 years	0.5	2.73
10 years	0.5	2.73

More quotes

Managers and Directors: Amerise Biosciences Limited

Manager	Title	Age	Since
Albert Hines DFI	Director of Finance/CFO	-	01/02/2026
Soni Pandiya CMP	Compliance Officer	-	14/04/2026

Director	Title	Age	Since
Manisha Maneklal Patel BRD	Director/Board Member	57	23/06/2019
Niraj Vijaybbai Vaghela BRD	Director/Board Member	29	22/07/2022
Albert Hines BRD	Director/Board Member	-	01/02/2026

More insiders

Shell Companies

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AMERISE BIOSCIENCES LIMITED	+3.26%	+18.75%	+20.25%	+35.71%	633K
CHURCHILL CAPITAL CORP VII	-0.30%	-.--%	-.--%	-3.57%	915M
EINRIDE AB	-1.44%	-25.02%	-	-	876M
CHURCHILL CAPITAL CORP XI	+11.37%	+0.69%	-	-	890M
PRIME BEING CORP.	-35.29%	-.--%	+44.74%	+391.07%	797M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	+0.05%	0.00%	-	-	643M
DEEP FISSION, INC.	+2.70%	+2.70%	-	-	643M
CHURCHILL CAPITAL CORP XII	+0.47%	-0.65%	-	-	600M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	-.--%	-.--%	-.--%	600M
CANTOR EQUITY PARTNERS IV, INC.	+0.10%	+0.10%	-	-	597M
Average	-1.91%	-0.27%	+16.25%	+105.80%	656.04M
Weighted average by Cap.	-2.66%	-3.03%	+15.42%	+133.37%

See all sector performances

Financials

	2024	2025
Net sales	359K 3.74K 3.27K 3.02K 2.79K 5.25K 5.35K 36.01K 14.13K 176K 14.04K 13.73K 605K	1.88M 19.57K 17.1K 15.81K 14.61K 27.51K 28.01K 189K 73.98K 921K 73.52K 71.89K 3.17M
Net income	-1.46M -15.21K -13.29K -12.29K -11.35K -21.38K -21.77K -147K -57.49K -715K -57.13K -55.87K -2.46M	57K 593.42 518.59 479.4 442.91 834.07 849.18 5.72K 2.24K 27.91K 2.23K 2.18K 96.1K
Net Debt	-211K -2.2K -1.92K -1.77K -1.64K -3.09K -3.14K -21.16K -8.3K -103K -8.25K -8.07K -356K	-222K -2.31K -2.02K -1.87K -1.73K -3.25K -3.31K -22.27K -8.74K -109K -8.68K -8.49K -374K